Trends in Outcomes After Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy

Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) have been shown to improve clinical outcomes among select patients presenting with peritoneal carcinomatosis. The aim of the present study was to describe temporal trends in clinical outcomes among patients undergoing CRS/HIPEC.Patients who underwent CRS/HIPEC were identified using the American College of Surgeons National Surgical Quality Improvement Program...